These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7138201)

  • 1. [Therapeutic effect of canrenoate potassium (soldactone) in patients after open-heart surgery].
    Matsuda K; Tatsuta N; Konishi Y; Minami K; Nishiwaki N; Yamasato A; Chiba Y; Ishihara H; Murata S; Shiraishi Y; Muraguchi T; Hikasa Y
    Nihon Geka Hokan; 1982 May; 51(3):519-27. PubMed ID: 7138201
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of potassium canrenoate in cardiosurgery].
    Tufano R; Scopa M; Brando G; Leone D
    Minerva Anestesiol; 1981 Apr; 47(4):149-54. PubMed ID: 7242963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of canrenoate potassium on intraoperative disturbances of electrolyte equilibrium].
    Eschner J; Fodor L; Ahnefeld FW
    Infusionsther Klin Ernahr; 1976 Apr; 3(2):98-104. PubMed ID: 965083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of Soludactone in cardiac surgery in adults].
    Fogliani J; Capuccio P; Goudard A; Guillen JC; Monties JR
    Ann Anesthesiol Fr; 1975; 16(3):189-96. PubMed ID: 241276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic report on an injectable aldosterone antagonist (K-canrenoate) in states of water-salf retention].
    Coltorti M; Radaeli E; Ciaccio S; Corsini R; Trebbi R
    Clin Ter; 1976 Feb; 76(3):215-34. PubMed ID: 963962
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of K-canrenoate in post-surgical treatment of open heart paediatric surgery (author's transl)].
    Capuani A; Bernabei M; Pasque A; Eufrate S
    G Ital Cardiol; 1980; 10(9):1148-55. PubMed ID: 7461364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canrenoate--a spironolactone metabolite. Acute cardiac effects in digitalized patients.
    Waldorff S; Buch J
    Eur J Cardiol; 1979 Aug; 10(2):143-9. PubMed ID: 477703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Extrarenal effects of potassium-canrenoate. Haemodynamic investigations during neuroleptanalgesia in cardiosurgical patients (author's transl)].
    Piepenbrock S; Hempelmann G; Schwarz S; Oelert H
    Anaesthesist; 1979 Apr; 28(4):163-70. PubMed ID: 312042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Potassium canreonate in neurosurgical brain edema].
    Mille T; Rodriguez R; Baena Y
    Minerva Chir; 1975 Jul 15-31; 30(13-14):781-9. PubMed ID: 1221307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of an aldosterone antagonist in abdominal surgery].
    Ribero F; Remonda G; Morachioli N; Pugnani M
    Ann Osp Maria Vittoria Torino; 1982; 25(1-6):61-70. PubMed ID: 7185311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Brain edema in neurosurgery. Trial with an aldosterone-antagonist (soldactone) (author's transl)].
    Anderes JP; de Tribolet N; Zander E
    Schweiz Rundsch Med Prax; 1977 Aug; 66(32):1020-6. PubMed ID: 556440
    [No Abstract]   [Full Text] [Related]  

  • 12. [Plasma hyperosmolarity aspects in intensive care and its treatment with potassium canreonate].
    Ruggerini R; Mazzocchi F; Albini G; Cifalinò M
    Minerva Anestesiol; 1979 Sep; 45(9):687-90. PubMed ID: 117400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of intravenous potassium canrenoate in patients with severe heart failure and digitalis toxicity.
    Cristodorescu R; Puschita M; Deutsch G; Berger E; Luca C
    Med Interne; 1977; 15(1):27-34. PubMed ID: 841250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of potassium canrenoate on arterial pressure, plasma renin activity and urinary aldosterone in essential hypertension].
    Opocher G; Armanini D; Fallo F; Mantero F
    Boll Soc Ital Cardiol; 1978; 23(10):1757-66. PubMed ID: 400390
    [No Abstract]   [Full Text] [Related]  

  • 15. [Interference of canrenoate potassium with plasma renin activity. Note I. Effects of canrenoate potassiumon plasma renin activity in patients with essential hypertension].
    Consolo F; Ferraù O; Pitrone F; Luzza G; Russo A; Virga T
    Boll Soc Ital Biol Sper; 1975 Dec; 51(24):1943-9. PubMed ID: 1231877
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of digitalis toxicity with intravenous potassium canrenoate.
    Gavrilescu G; Cristodorescu R; Deutsch G; Berger E
    Agressologie; 1977; 18(3):167-71. PubMed ID: 920909
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of canrenoate potassium given orally in ascitogenic cirrhosis].
    Sarti F; Milandri GL; Piemontese A; Macchia S; Simoni S; Dal Monte PR
    Minerva Dietol Gastroenterol; 1984; 30(3):273-80. PubMed ID: 6504377
    [No Abstract]   [Full Text] [Related]  

  • 18. [Efficacy of canrenoate potassium in hypertensive cardiopathy. Clinical and echocardiographic evaluation].
    Caporicci D; Achilli L
    Minerva Cardioangiol; 1984 Sep; 32(9):581-7. PubMed ID: 6514202
    [No Abstract]   [Full Text] [Related]  

  • 19. [Value of potassium canrenoate in the prevention of arrhythmia during the acute phase of myocardial infarction].
    Denis B; Machecourt J; Denis MC; Morena H; Pellet J; Rossignol B; Martin-Noël P
    Arch Mal Coeur Vaiss; 1979 Sep; 72(9):1014-22. PubMed ID: 116612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Indication and experience with an intravenously administered aldosterone-antagonist (soldactone) (author's transl)].
    Kirsch R
    Schweiz Rundsch Med Prax; 1975 Nov; 64(44):1414-7. PubMed ID: 1236699
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.